المؤلفون: Caimi, Paolo F, Ai, Weiyun, Alderuccio, Juan Pablo, Ardeshna, Kirit M, Hamadani, Mehdi, Hess, Brian, Kahl, Brad S, Radford, John, Solh, Melhem, Stathis, Anastasios, Zinzani, Pier Luigi, Havenith, Karin, Feingold, Jay, He, Shui, Qin, Yajuan, Ungar, David, Zhang, Xiaoyan, Carlo-Stella, Carmelo

المصدر: Caimi , P F , Ai , W , Alderuccio , J P , Ardeshna , K M , Hamadani , M , Hess , B , Kahl , B S , Radford , J , Solh , M , Stathis , A , Zinzani , P L , Havenith , K , Feingold , J , He , S , Qin , Y , Ungar , D , Zhang , X & Carlo-Stella , C 2021 , ' Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2) : a multicentre, open-label, single-arm, phase 2 trial ' ....

مصطلحات موضوعية: Adolescent, Adult, Aged, Antibodies, Monoclonal, Humanized/administration & dosage, Antigens, CD19/drug effects, Benzodiazepines/administration & dosage, Drug-Related Side Effects and Adverse Reactions/classification, Female, Humans, Immunoconjugates/administration & dosage, Italy/epidemiology, Lymphoma, Large B-Cell, Diffuse/drug therapy, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy, Recurrence, Switzerland/epidemiology, Young Adult, ResearchInstitutes_Networks_Beacons/mcrc, Manchester Cancer Research Centre

الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00139-X
https://research.manchester.ac.uk/en/publications/f1185252-6a3a-4377-a63f-f9054cdc1701Test

المؤلفون: Ton, N. C., Parker, G. J M, Jackson, A., Mullamitha, S., Buonaccorsi, G. A., Roberts, C., Watson, Y., Davies, K., Cheung, S., Hope, L., Power, F., Lawrance, J., Valle, J., Saunders, M., Felix, R., Soranson, J. A., Rolfe, L., Zinkewich-Peotti, K., Jayson, Gordon C.

المصدر: Ton , N C , Parker , G J M , Jackson , A , Mullamitha , S , Buonaccorsi , G A , Roberts , C , Watson , Y , Davies , K , Cheung , S , Hope , L , Power , F , Lawrance , J , Valle , J , Saunders , M , Felix , R , Soranson , J A , Rolfe , L , Zinkewich-Peotti , K & Jayson , G C 2007 , ' Phase I evaluation of CDP791, a PEGylated Di-Fab′ conjugate that binds vascular endothelial growth factor ....

مصطلحات موضوعية: Adolescent, Adult, Aged, 80 and over, Angiogenesis Inhibitors/*administration & dosage/adverse, effects/pharmacokinetics, Cohort Studies, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Immunoconjugates/*administration & dosage/adverse effects/pharmacokinetics, Immunoglobulin Fab Fragments/*administration & dosage/adverse, effects/metabolism, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasms/blood supply/*drug therapy, Polyethylene Glycols/*administration & dosage/adverse, Vascular Endothelial Growth Factor Receptor-2/*antagonists &, inhibitors/blood

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-07-1550Test
https://research.manchester.ac.uk/en/publications/adc88d83-1c4a-433d-9691-e35bc61bfcd5Test
http://clincancerres.aacrjournals.org/cgi/reprint/13/23/7113Test
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18056191Test